Na Cocer Peptides bin rayt am 
1 mɔnt dɔn pas
ƆL DI ATIKUL ƐN PRODƆKT INFƆMƐSHƆN WE DƐN GI NA DIS WƐBSAYT NA FƆ ƆL FƆ DI INFƆMƐSHƆN ƐN FƆ EDYUKESHƆN.
Di prɔdak dɛn we dɛn gi na dis wɛbsayt na fɔ in vitro risach nɔmɔ. in vitro risach (Latin: *in glas*, we min insay glas) dεn de du am ausayd mכtalman bכdi. Dɛn prɔdak ya nɔto mɛrɛsin, dɛn nɔ gɛt di aprɔval frɔm di US Food and Drug Administration (FDA), ɛn dɛn nɔ fɔ yuz dɛn fɔ protɛkt, trit, ɔ mɛn ɛni mɛrɛsin, sik, ɔ sik. Di lɔ nɔ gri fɔ mek dɛn put dɛn tin ya insay mɔtalman ɔ animal bɔdi ɛni we.
Ovaviu fɔ di tin dɛn we dɛn dɔn lan
Bam15, as selektiv maytochondrial uncoupler, dεn bin aplay in mεtabolik-rεlatεd risεch fil dεm insay di rεsεnt ia, we de gi nyu tritmεnt opshכn fכ difrεn mεtabolik sik dεm. di maytochכndria dεm de ple sεntri rol insay sεlyul εnεji mεtabolism, we de rispansabl fכ jεnarεt ATP tru כksidεtiv fכsfכrayleshכn, we de gi enεji fכ difrεn sεlyul aktiviti dεm. insay sכm patכlayz stet dεm, di maytochכndrial fכnshכn kin bכku, we kin mek i gεt mεtabolik dizכrd εn i kin kכlכs wit di biginin εn prכgreshכn fכ sik dεm lεk fכ fat, dayabitis, εn nכn-alkohol fεt liva sik.
Bam15 spεshal tכgεt di maytochכndria dεm εn, tru wan yכnik mεkanism fכ akshכn, i de disrupt di tayt kכpl bitwin εlektrכn transpכt εn ATP sεntesis. i de protεkt di bakfכlכ fכ protכn dεm akraos di insay maytochכndrial mεmbran, we de mek di protכn grεdiεnt dεm, we de alaw di maytochכndrial rεspiretכri chen fכ kכntinyu fכ fכnshכn bכt i de ridyus di efyushכn fכ ATP sεntesis. dis uncoupling ifekt gεt imכtant fisiolכjik signifyans, as i de protεkt di maytochכndrial respirashכn, inkrεs εnεji kכnsכmshכn, εn disipεt enεji in fכm fכ hεt, we de rεgεl di bכdi in enεji mεtabolism bεlε.
Figure 1 Mεkanism fכ BAM15-indyus כnkכpl כksidεtiv fכsfכrayleshכn.
Ifɛkt dɛn
fכ protεkt εnεji mεtabolism: Bam15 de bכku bכku wan εnhans di bכdi in εnεji mεtabolism lεvεl dεm tru di maytochכndrial uncoupling mεkanism dεm. כnda nכmal fysiolojikal kכndishכn dεm, sεlyul εnεji mεtabolism de stil de insay wan rili stebul stet fכ sכstayn nכmal fysiolojikal fכnshכn dεm. We di bɔdi it bɔku ɛnaji we pɔsin nɔ go ebul fɔ it kwik kwik wan, di ɛnaji we pas am kin kip as fat, we kin mek i gɛt bɔku bɔku bɔdi ɛn fat. Bam15 de disrupt dis bεlε bay we i de aktibכt di maytochכndrial rεspireshכn, we de mek di sabstεt dεm insay di sεl dεm ebul fכ כksidayz εn dεkכmpכz mכr kwik, we de mek di εnεji we dεn de spεnd εn ridyus di fεt akyumyuleshכn. insay animal εkspεriεns, mays dεm we dεn trit wit Bam15 sho sכmtεm sכpres wet gεn ivin כnda wan hεy-fεt it, we sho klia wan di rol we Bam15 de ple fכ protεkt εnεji mεtabolism.
fכ mek di insulin rεsistεns bכku: di insulin rεsistεns na wan pan di ki pathophysiological mεkanism dεm we de כndalayn di divεlכpmεnt fכ tayp 2 dayabεtis. insay wan stet we insulin rεsistεnt, di sεnsitiviti fכ di bכdi tisu dεm to insulin de dכn, we de mek insulin nכ de mek di glukכs tek εn yutilizeshכn fayn fayn wan, we de mek di glukכs lεvεl dεm na di bכdi go εlevεt. Bam15 kin impruv insulin rεsistεns tru mכltipכl path dεm. i de mek di enεji mεtabolism, we de ridyus di fεt we pasmak na di tisu dεm, patikyular di vishכnal fεt. di fεt tisu we pasmak de kכl bכku inflammatory fכktכ dεm εn adipokines, we de intafεr di nכmal transmishכn fכ insulin signal path dεm, we de mek di insulin rεsistεns. afta i dכn ridyus di fεt akyumyuleshכn, Bam15 de dכn di inflammatory rεspכns dεm, we de mek di insulin signal path fכ wok fayn. Bam15 kin akt bak dayrekt pan intasεlulyar insulin signal mכlikul dεm, we de εnhans insulin signal transmishכn εn inkrεs sεl sεnsitiviti to insulin, we de mek sεl dεm bεtε fכ tek εn yuz glukכs, we de mek di bכdi glukכs lεvεl dכn.
fכ protεkt di maytochכndrial כtofagi: di maytochכndrial כtofagi na imכtant mεkanism fכ di sεl dεm fכ mεnten di maytochכndrial kwaliti εn fכnshכn. we di maytochכndria dεm dכn dכn כ we dεn nכ de wok fayn, di sεl dεm de initiate di maytochכndrial כtofagi prכsεs, we de kapsul di maytochכndria dεm we dεn dכn dכn εn transpכt dεm to laysosom dεm fכ dεgradashכn fכ mεnten di hεlth fכ di maytochכndrial populeshכn insay di sεl. כnda patכlayz kכndishכn dεm lεk it we gεt hεy fεt, di maytochכndria dεm kin pwεl, we kin mek di maytochכndria dεm nכ de wok fayn εn i kin mek di mεtabolik dizכrd dεm mכr bכku. Bam15 sכmtεm de protεkt di maytochכndrial כtofagi bay we i de upregulate di εksprεshכn fכ di maytochכndrial כtofagi mak jin dεm Pink1 εn Parkin, we de mek di sεl dεm kכl di maytochכndria dεm we dεn dכn pwεl kwik kwik wan, impruv di maytochכndrial kwaliti kכntrכl, rεstכr nכmal maytochכndrial fכnshכn, εn mεnten di sεl εnεji mεtabolik homכstasis.
rεgulεshכn fכ di lipid mεtabolism: Bam15 de ple imכtant rol fכ rεgεl di lipid mεtabolism. i de mek lipolysis insay di εpatosayt dεm, i de inhibit di lipid sεntesis, εn i de ridyus di lipid akyumyuleshכn na di liva. insay patכlayz stet dεm lεk haypa lipidemia, di εlevεt lipid lεvεl dεm na di bכdi de mek di lipid dεm we de kכmכt pasmak na di tisu dεm lεk di liva, we de trigεr di lipid-rεlatεd patכlayzm dεm lεk steatosis. Bam15 de mכdulet di aktiviti fכ di εnzym dεm we de involv insay lipid mεtabolism, lεk fכ promuot di εksprεshכn fכ di εnzym dεm we riliyt to fεt asid כksidεshכn εn fכ inhεbit di aktvכti fכ fεt asid sεntez εnzym dεm, we de mek fεt asid כksidεshכn εn dεkכmpozishכn inkrεs we i de ridyus sεntesis. dis de mek di lipid lεvεl dεm na di liva εn bכdi dכn, we de mek di lipid mεtabolism dizכrd dεm bכku.
Aplikeshɔn dɛn
Tritmɛnt fɔ fat: Fɔ fat dɔn bi wan tin we de apin ɔlsay na di wɔl ɛn i gɛt fɔ du wit di biginin fɔ difrɛn sik dɛn we nɔ de mɛn. biכs fכ in abiliti fכ promuot enεji mεtabolism εn ridyus fεt akyumyuleshכn, Bam15 sho big pכtεnshal fכ trit fכ fat. Animal εkspεriεns risכlt sho se fat mays dεm we dεn trit wit Bam15 bin εkspiriεns sכm weit lכs, impruv bכdi kכmכshכn, rεdכks fεt kכntεnt, εn rili inkrεs sכm mכsul kכntεnt. So, Bam15 kin sav as pɔtɛnɛshɛl tritmɛnt ɛjɛn fɔ ɔbisiti tritmɛnt bay we i de rigul ɛnaji balans, ɛp fɔ lɔs wet pan fat pasɛnt dɛn, ɛn ridyus di risk fɔ ɔbisiti-rilayt kɔmplikeshɔn dɛn.
Dayabitis Tritmɛnt: We wi tink bɔt di impɔtant wok we Bam15 de du fɔ mek di insulin nɔ de wok fayn ɛn fɔ mek di glukɔs we de na di blɔd bɛtɛ, i dɔn gɛt bɔku atɛnshɔn pan dayabitis tɛrapi. Prεklinik stכdi dεn sho se Bam15 kin εnhans insulin sεnsitiviti insay dayabεtik animal mכdel dεm, lכs di blכd glukכs lεvεl, εn impruv di impεriכs glukכs tכlerεns. Dis de gi nyu we ɛn pɔtnɛshɛl drɔg opshɔn fɔ dayabitis tritmɛnt. We yu kɔmpia am wit tradishɔnal dayabitis mɛrɛsin, Bam15 de rigul di mɛtabolism tru wan spɛshal we, we de kɔntrol di blɔd glukɔs lɛvɛl fayn fayn wan we nɔ de kɔz siriɔs sayd ifɛkt lɛk haypoglycemia, we de gi bɛtɛ tritmɛnt autkam fɔ di wan dɛn we gɛt dayabitis.
Tritmɛnt fɔ di sik we nɔ gɛt alkol fat liva: Nɔn-alkohol fat liva sik na kɔmɔn mɛtabolik liva sik we dɛn kin kɔl we di lipid kin gɛda pasmak na di liva. Bam15 kin ridyus di hεpatik steatosis fayn fayn wan εn impruv di liva fכnshכn bay we i de rεgεl di lipid mεtabolism εn i de promuot di maytochכndrial כtofagi. insay animal εkspεriεns, nכn-alkohol fεt liva sik mכdel animal dεm we dεn trit wit Bam15 sho sכm sכm rεdukshכn pan liva lipid kכntεnt εn impruv liva fכnshכn mak dεm.
Ɛksplen
Bam15 de tכk bכt di maytochכndrial mεtabolism, we de ple rol insay di kכl prכsεs dεm lεk enεji imbalans, insulin rεsistεns, lipid dizכrd, εn mitochondrial kwaliti kכntrכl, we de gi nyu tεrapi stratεji fכ mεtabolik sik dεm lεk fכ fat, dayabitis, εn fεt liva sik, εn bak di kכmplikεshכn dεm we de asai fכ dεn.
Sos dɛn we dɛn pul
[1] Xiong G, Zhang K, Ma Y, ɛn ɔda pipul dɛn. BAM15 as maytochondrial uncoupler: wan prכmis tεrapi ejen fכ difrεn sik dεm[J]. Frɔntiɛr in Ɛndokrinɔlɔji, 2023,14:1252141.DOI:10.3389/fendo.2023.1252141.
[1] Paris V, Alɛksɔpɔlɔs S, H. H. Y., ɛn ɔda pipul dɛn. Mitochondrial Uncoupler BAM15 Ameliorate Assosiet Mεtabolik PCOS Trayt dεm in wan Hayparandrojεnik PCOS Maus Mכdel[J]. Fɛtiliti & Riprodakshɔn, 2022,04:208.DOI:10.1142/S266 13182227411 94.
Prodak we de fɔ yuz fɔ risach nɔmɔ:
